Informet Tablet 850 mg is an oral antidiabetic medication containing metformin hydrochloride, a widely recommended first-line therapy for the management of type 2 diabetes mellitus. This higher-strength formulation is intended for patients who require greater glycemic control as part of their ongoing diabetes treatment. Informet Tablet 850 mg helps lower elevated blood glucose levels effectively while supporting insulin sensitivity and metabolic balance. It is commonly prescribed as monotherapy or in combination with other antidiabetic agents when diet and exercise alone are insufficient.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active ingredient: Metformin Hydrochloride 850 mg
Dosage form: Film-coated tablet
Route of administration: Oral
Biguanide antidiabetic agent
Metformin exerts its antihyperglycemic effect through multiple complementary mechanisms. It primarily reduces hepatic glucose production by inhibiting gluconeogenesis in the liver. In addition, it enhances insulin sensitivity in peripheral tissues such as skeletal muscle and adipose tissue, leading to increased glucose uptake and utilization. Metformin also decreases intestinal absorption of glucose. Importantly, it does not stimulate insulin secretion, which significantly reduces the risk of hypoglycemia when used alone.
Informet Tablet 850 mg is indicated for:
Management of type 2 diabetes mellitus in adults
Glycemic control in patients not adequately controlled with lower doses of metformin
Use as monotherapy or in combination with other oral antidiabetic agents or insulin
Adjunct to diet and lifestyle modification for effective diabetes management
Provides stronger glycemic control with a higher metformin dose
Helps reduce fasting and postprandial blood glucose levels
Improves insulin sensitivity without promoting weight gain
Low risk of hypoglycemia when used alone
Suitable for long-term management of type 2 diabetes
Dosage should be individualized according to patient response and tolerability.
Commonly taken 1–2 times daily with meals to minimize gastrointestinal side effects.
Tablets should be swallowed whole with water and not crushed or chewed.
Dose adjustments should be made gradually under medical supervision.
Regular monitoring of blood glucose and renal function is recommended.
Use with caution in patients with renal or hepatic impairment.
Kidney function should be assessed before starting therapy and monitored periodically.
Temporary discontinuation may be required before major surgery or diagnostic procedures involving iodinated contrast agents.
Contraindicated in patients with severe renal dysfunction, metabolic acidosis, or conditions associated with tissue hypoxia.
Patients should inform their healthcare provider about all concomitant medications.
Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, and decreased appetite, particularly at the start of therapy. These effects are usually mild and improve with continued use. Rarely, lactic acidosis may occur, especially in patients with significant renal impairment.
Store in a cool, dry place away from moisture and direct sunlight.
Keep out of reach of children.
Informet Tablet 850 mg (Metformin Hydrochloride) is an effective and well-established antidiabetic medication for patients requiring enhanced glycemic control. With its proven efficacy, safety profile, and metabolic benefits, it remains a cornerstone therapy in the long-term management of type 2 diabetes mellitus.
Login Or Registerto submit your questions to seller
No none asked to seller yet